Fabrication of hesperidin nanoparticles loaded by poly lactic co-Glycolic acid for improved therapeutic efficiency and cytotoxicity

References

• Bharali DJ, Mousa SA. Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise. Pharmacol Ther. 2010;128:324–335.
   PubMed Web of Science ®Google Scholar
• Sutradhar KB, Amin L. Nanotechnology in cancer drug delivery and selective targeting. ISRN Nanotechnol. 2014;2014:1–12.
   Google Scholar
• Abdollahi A, Ali-Bakhshi A, Farahani Z. Concentration study of high sensitive c - reactive protein and some serum trace elements in patients with benign and malignant breast tumor. Int J Hematol-Oncol Stem Cell Res. 2015;9:180–184.
   PubMedGoogle Scholar
• Broustas CG, Lieberman HB. DNA damage response genes and the development of cancer metastasis. Radiat Res. 2014;181:111–130.
   PubMed Web of Science ®Google Scholar
• Singh OP, Nehru RM. Nanotechnology and cancer treatment. Asian J Exp Sci. 2008;22:45–50.
   Google Scholar
• Chidambaram M, Manavalan R, Kathiresan K. Nanotherapeutics to overcome conventional cancer chemotherapy limitations. J Pharm Pharm Sci. 2011;14:67–77.
   PubMed Web of Science ®Google Scholar
• Batra P, Sharma AK. Anti-cancer potential of flavonoids: recent trends and future perspectives. 3 Biotechnology. 2013;3:439–459.
   PubMedGoogle Scholar
• Del Rio D, Rodriguez-Mateos A, Spencer JP, et al. Dietary (Poly) phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxidants Redox Signal. 2013;18:1818–1892.
   PubMed Web of Science ®Google Scholar
• Devi KP, Rajavel T, Nabavi SF, et al. Hesperidin: a promising anticancer agent from nature. Indust Crops Prod. 2015;76:582–589.
   Web of Science ®Google Scholar
• Panche AN, Diwan AD, Chandra SR. Flavonoids: an overview. J Nutr Sci. 2016;5:e47.
   PubMed Web of Science ®Google Scholar
• Li C, Schluesener H. Health-promoting effects of the citrus flavanone hesperidin. Crit Rev Food Sci Nutr. 2017;57:613–631.
   PubMed Web of Science ®Google Scholar
• Banjerdpongchai R, Wudtiwai B, Khaw-on P, et al. Hesperidin from citrus seed induces human hepatocellular carcinoma hepg2 cell apoptosis via both mitochondrial and death receptor pathways. Tumor Biol. 2016;37:227–237.
   PubMed Web of Science ®Google Scholar
• Wang Y, Yu H, Zhang J, et al. Hesperidin inhibits HeLa cell proliferation through apoptosis mediated by endoplasmic reticulum stress pathways and cell cycle arrest. BMC Cancer. 2015;15:682.
   PubMed Web of Science ®Google Scholar
• Ghorbani A, Nazari M, Jeddi-Tehrani M, et al. The citrus flavonoid hesperidin induces p53 and inhibits NF-kB activation in order to trigger apoptosis in NALM-6 cells: involvement of PPARγ - dependent mechanism. Eur J Nutr. 2012;51:39–46.
   PubMed Web of Science ®Google Scholar
• Lee KA, Lee SH, Lee YJ, et al. Hesperidin induces apoptosis by inhibiting Sp1 and its regulatory protein in MSTO-211H cells. Biomol Ther. 2012;20:273–279.
   PubMed Web of Science ®Google Scholar
• Saiprasad G, Chitra P, Manikandan R, et al. Hesperidin induces apoptosis and triggers autophagic markers through inhibition of Aurora-A mediated phosphoinositide-3-Kinase/Akt/Mammalian target of rapamycin and glycogen synthase kinase-3 beta signalling cascades in experimental colon carcinogenesis. Eur J Cancer. 2014;50:2489–2507.
   PubMed Web of Science ®Google Scholar
• Majumdar S, Srirangam R. Solubility, stability, physicochemical characteristics and in vitro ocular tissue permeability of hesperidin: a natural bioflavonoid. Pharm Res. 2009;26:1217–1225.
   PubMed Web of Science ®Google Scholar
• Loganathan N, Sellappan M. Designing of nanosized bioflavonoids using biodegradable polymeric nanoparticles by plackett burman method. Int Curr Pharm J. 2017;6:9–15.
   Google Scholar
• Bilia AR, Isacchi B, Righeschi C, et al. Flavonoids loaded in nanocarriers: an opportunity to increase oral bioavailability and bioefficacy. Fns. 2014;05:1212–1227.
   Google Scholar
• Bharali DJ, Siddiqui IA, Adhami VM, et al. Nanoparticle delivery of natural products in the prevention and treatment of cancers: current status and future prospects. Cancer. 2011;3:4024–4045.
   Google Scholar
• Malam Y, Loizidou M, Seifalian AM. Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. Trends Pharmacol Sci. 2009;30:592–599.
   PubMed Web of Science ®Google Scholar
• Sutradhar KB, Amin ML. Nanoemulsions: increasing possibilities in drug delivery. Eur J Nanomed. 2013;5:97–110.
   Google Scholar
• Sulaiman GM, Jabir MS, Hameed AH. Nanoscale modification of chrysin for improved of therapeutic efficiency and cytotoxicity. Artif Cells, Nanomed Biotechnol. 2018;1–13. DOI: 10.1080/21691401.2018.1434661.
   Web of Science ®Google Scholar
• Sulaiman GM, Al Sammarrae KW, Ad’hiah AH, et al. Chemical characterization of Iraqi propolis samples and assessing their antioxidant potentials. Food Chem Toxicol. 2011;49:2415–2421.
   PubMed Web of Science ®Google Scholar
• Frisch MJ, Trucks GW, Schlegel HB, et al. Gaussian 09, Revision A.02, Gaussian Inc., Wallingford, CT, USA; 2009.
   Google Scholar
• Benhusein GM, Mutch E, Aburawi S, et al. Genotoxic effect induced by hydrogen peroxide in human hepatoma cells using comet assay. Libyan J Med. 2010;5:1-6. DOI: 10.3402/ljm.v5i0.4637.
   Web of Science ®Google Scholar
• Abd El-Rahman SN, Al-Jameel SS. Protection of curcumin and curcumin nanoparticles against cisplatin induced nephrotoxicity in male rats. Scholars Acad J Biosci. 2014;2:214–223.
   Google Scholar
• Dokoumetzidis A, Macheras P. A century of dissolution research: from noyes and whitney to the biopharmaceutics classification system. Int J Pharm. 2006;321:1–11.
   PubMed Web of Science ®Google Scholar
• Tzeng CW, Yen FL, Wu TH, et al. Enhancement of dissolution and antioxidant activity of kaempferol using a nanoparticle engineering process. J Agric Food Chem. 2011;59:5073–5080.
   PubMed Web of Science ®Google Scholar
• Gurushankar K, Gohulkumar M, Prasad NR, et al. Synthesis, characterization and in vitro anti-cancer evaluation of hesperetin-loaded nanoparticles in human oral carcinoma (KB) cells. Adv Nat Sci: Nanosci Nanotechnol. 2014;5:015006.
   Web of Science ®Google Scholar
• Rejinold NS, Muthunarayanan M, Chennazhi KP, et al. 5-fluorouracil loaded fibrinogen nanoparticles for cancer drug delivery applications. Int J Biol Macromol. 2011;48:98–105.
   PubMed Web of Science ®Google Scholar
• Krishnakumar N, Sulfikkarali N, Rajendra Prasad N, et al. Enhanced anticancer activity of naringenin-loaded nanoparticles in human cervical (HeLa) cancer cells. Biomed Prev Nutr. 2011;1:223–231.
   Google Scholar
• Gao H, Chen Y, Ma H, et al. Preparation and characterization of hesperidin - PEG 6000 complex. J Chem Soc Pakistan. 2014;36:848–851.
   Web of Science ®Google Scholar
• Torrado G, Fraile S, Torrado S, et al. Process-induced crystallite size and dissolution changes elucidated by a variety of analytical methods. Int J Pharm. 1998;166:55–63.
   Web of Science ®Google Scholar
• Khadka P, Ro J, Kim H, et al. Pharmaceutical particle technologies: an approach to improve drug solubility, dissolution and bioavailability. Asian J Pharm Sci. 2014;9:304–316.
   Google Scholar
• Cho SA, Cha SR, Park SM, et al. Effects of hesperidin loaded poly (lacticco-glycolic acid) scaffolds on growth behavior of costal cartilage cells in vitro and in vivo. J Biomaterials Sci Polym Ed. 2014;25:625–640.
   PubMed Web of Science ®Google Scholar
• Moghimi SM, Hunter AC. Poloxamers and poloxamines in nanoparticle engineering and experimental medicine. Trends Biotechnol. 2000;18:412–420.
   PubMed Web of Science ®Google Scholar
• Mauludin R, Muller RH. Physicochemical properties of hesperidin nanocrystal. Int J Pharm Pharmaceu Sci. 2013;5:954–960.
   Google Scholar
• Sulaiman GM. Molecular structure and anti-proliferative effect of galangin in HCT-116 cells: in vitro study. Food Sci Biotechnol. 2016;25:247–252.
   PubMed Web of Science ®Google Scholar
• Mishra K. Structure-activity relationship of antioxidative property of hesperidin. Int J Pharm Erud. 2013;2:40–53.
   Google Scholar
• Kalpana KB, Srinivasan M, Menon VP. Evaluation of antioxidant activity of hesperidin and its protective effect on H2O2 induced oxidative damage on pBR322 DNA and RBC cellular membrane. Mol Cell Biochem. 2009;323:21–29.
   PubMed Web of Science ®Google Scholar
• Cai W, Chen Y, Xie L, et al. Characterization and density functional theory study of the antioxidant activity of quercetin and its sugar-containing analogues. Eur Food Res Technol. 2014;238:121–128.
   Web of Science ®Google Scholar
• Hosseinimehr SJ, Jalayer Z, Naghshvar F, et al. Hesperidin inhibits cyclophosphamide-induced tumor growth delay in mice. Integr Cancer Ther. 2012;11:251–256.
   PubMed Web of Science ®Google Scholar
• Choi J, Reipa V, Hitchins VM, et al. Physicochemical characterization and in vitro hemolysis evaluation of silver nanoparticles. Toxicol Sci. 2011;123:133–143.
   PubMed Web of Science ®Google Scholar
• Coutinho L, Oliveira H, Pacheco AR, et al. Hesperetin-etoposide combinations induce cytotoxicity in U2OS cells: implications on therapeutic developments for osteosarcoma. DNA Repair (Amst). 2017;50:36–42.
   PubMed Web of Science ®Google Scholar
• Al-Ashaal HA, El-Sheltawy ST. Antioxidant capacity of hesperidin from citrus peel using electron spin resonance and cytotoxic activity against human carcinoma cell lines. Pharm Biol. 2011;49:276–282.
   PubMed Web of Science ®Google Scholar
• Makin G, Hickman JA. Apoptosis and cancer chemotherapy. Cell Tissue Res. 2000;301:143–152.
   PubMed Web of Science ®Google Scholar
• Natarajan N, Thamaraiselvan R, Lingaiah H, et al. Effect of flavonone hesperidin on the apoptosis of human mammary carcinoma cell line MCF-7. Biomed Prev Nutr. 2011;1:207–215.
   Google Scholar
• Park HJ, Kim MJ, Ha E, et al. Apoptotic effect of hesperidin through caspase3 activation in human colon cancer cells, SNU-C4. Phytomedicine. 2008;15:147–151.
   PubMed Web of Science ®Google Scholar
• Chahar MK, Sharma N, Dobhal MP, et al. Flavonoids: a versatile source of anticancer drugs. Phcog Rev. 2011;5:1–12.
   Google Scholar
• Gaspar J, Laires A, Monteiro M, et al. Quercetin and the mutagenicity of wines. Mutagenesis. 1993;8:51–55.
   PubMed Web of Science ®Google Scholar
• Flower NA, Brabu B, Revathy M, et al. Characterization of synthesized silver nanoparticles and assessment of its genotoxicity potentials using the alkaline comet assay. Mutat Res. 2012;742:61–65.
   PubMed Web of Science ®Google Scholar
• Valavanidis A, Vlachogianni T, Fiotakis C. 8-hydroxy-2'-deoxyguanosine (8-OHdG): A critical biomarker of oxidative stress and carcinogenesis. J Environ Sci Health, Part C: Environ Carcinogen Ecotoxicol Rev. 2009;27:120–139.
   Google Scholar
• Baskar R, Lee KA, Yeo R, et al. Cancer and radiation therapy: current advances and future directions. Int J Med Sci. 2012;9:193–199.
   PubMed Web of Science ®Google Scholar